
DAEWOONG PHARMA — Investor Relations & Filings
Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 투자판단관련주요경영사항 | 2025-10-27 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-15 | Korean | |
| 최대주주등소유주식변동신고서 | 2025-10-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-14 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-01 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2025-10-01 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 33026974 | 투자판단관련주요경영사항 | 2025-10-27 | Korean | ||
| 33024235 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-15 | Korean | ||
| 33024232 | 최대주주등소유주식변동신고서 | 2025-10-15 | Korean | ||
| 33023905 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-14 | Korean | ||
| 33022207 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-01 | Korean | ||
| 33022105 | 주식등의대량보유상황보고서(약식) | 2025-10-01 | Korean | ||
| 33019400 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-09-23 | Korean | ||
| 33019399 | 최대주주등소유주식변동신고서 | 2025-09-23 | Korean | ||
| 7864287 | 투자판단관련주요경영사항 | 2025-09-15 | Korean | ||
| 7866480 | 투자판단관련주요경영사항 | 2025-09-05 | Korean | ||
| 7871333 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-08-18 | Korean | ||
| 7871330 | 최대주주등소유주식변동신고서 | 2025-08-18 | Korean | ||
| 7871758 | [기재정정]사업보고서 (2024.12) | 2025-08-14 | Korean | ||
| 7871685 | 반기보고서 (2025.06) | 2025-08-14 | Korean | ||
| 7880333 | 영업(잠정)실적(공정공시) | 2025-07-31 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
DAEWOONG PHARMA via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16576/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16576 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16576 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16576 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16576}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DAEWOONG PHARMA (id: 16576)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.